A diffusible substance(s) mediates endothelium-dependent contractions in the aorta of SHR.
A modified bioassay system was designed to demonstrate the diffusible nature of endothelium-derived contracting factor(s) released by acetylcholine in the aorta of spontaneously hypertensive rat. In "sandwich"-like layered preparation, isometric tension was recorded from a bioassay strip (without endothelium) in the presence of N(G)-nitro-L-arginine and tetrahydrobiopterin to selectively potentiate endothelium-dependent contractions. A donor strip (with or without endothelium) was stitched on the bioassay tissue so that it did not directly contribute to the recorded contractions. Acetylcholine induced contractions that occurred only when the donor strip was with endothelium. Superoxide dismutase did not affect but catalase and the combination of superoxide dismutase plus catalase significantly decreased the endothelium-dependent contraction. The contractions in the layered preparations were abolished when the donor strip with endothelium was treated previously with valeryl salicylate, an irreversible cyclooxygenase-1 inhibitor, but remained unaffected when the bioassay strip was treated with the compound. Previous treatment of the bioassay strip alone with S 18886 abolished the contractile response, whereas treatment of the donor strip with endothelium by the selective TP receptor antagonist only produced a moderate inhibition. These results indicate that in the aorta of spontaneously hypertensive rats, endothelium-dependent contractions to acetylcholine involve a diffusible substance(s) released by the endothelium. The production of this contracting factor(s) requires the activation of endothelial cyclooxygenase-1, and its action the activation of TP receptors on the vascular smooth muscle cells.
Yang
Di
D
Jiangsu Province Hospital, First Affiliated Hospital of Nanjing Medical University, Nanjing, Peoples Republic of China.
Félétou
Michel
M
Levens
Nigel
N
Zhang
Ji Nan
JN
Vanhoutte
Paul M
PM
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000503:physiopathology*; D001681:Biological Assay / Q000379:methods; D001708:Biopterins / Q000031:analogs & derivatives* / Q000494:pharmacology; D051545:Cyclooxygenase 1; D004058:Diffusion; D004730:Endothelium, Vascular / Q000737:chemistry / Q000201:enzymology / Q000503:physiopathology*; D006973:Hypertension / Q000201:enzymology / Q000378:metabolism / Q000503:physiopathology*; D007527:Isoenzymes / Q000032:analysis / Q000502:physiology; D008297:Male; D008565:Membrane Proteins; D009131:Muscle, Smooth, Vascular / Q000737:chemistry; D011451:Prostaglandin-Endoperoxide Synthases / Q000032:analysis / Q000502:physiology; D051381:Rats; D011918:Rats, Inbred SHR; D017382:Reactive Oxygen Species / Q000378:metabolism; D017482:Receptors, Thromboxane / Q000032:analysis / Q000502:physiology; D014661:Vasoconstriction; D014662:Vasoconstrictor Agents / Q000032:analysis / Q000494:pharmacology*
D007527:Isoenzymes; D008565:Membrane Proteins; D017382:Reactive Oxygen Species; D017482:Receptors, Thromboxane; D014662:Vasoconstrictor Agents; D001708:Biopterins; D051545:Cyclooxygenase 1; D011451:Prostaglandin-Endoperoxide Synthases; C496513:Ptgs1 protein, rat; C003402:sapropterin; D000109:Acetylcholine